The role of human papillomavirus marker p16 in identifying the primary focus in patients with metastases of squamous cell carcinoma from an undiagnosed primary focus

Cover Page

Cite item

Full Text

Abstract

Introduction. Squamous cell carcinoma of the oropharynx associated with Human papilloma virus (Hpv) has been identified as a distinct nosological unit among squamous cell carcinoma of the head and neck. This is due to the peculiarities of the disease and localization (the tumor mainly occurs in the palatine or lingual tonsils). primary squamous cell carcinoma of the oropharynx often debuts in the form of cancer metastases from an undiagnosed primary focus.

Aim. To show relationship between presence of the Hpv marker p16 in patients with metastases from an undiagnosed primary focus with primary squamous cell carcinoma of the oropharynx.

Materials and methods. The retrospective study included 151 patients with cervical lymph node metastases from an undiagnosed primary focus, treated from 2014 to 2024 in the Oncology Department of Surgical methods of Treatment No. 10 of the N. N. Blokhin National medical Center of Oncology, 83 of whom were found to have p16 – a surrogate marker of Hpv.

Results. The findings suggest a strong relationship between the presence of Hpv in the metastatic focus and oropharyngeal squamous cell carcinoma. The difficulty of identifying the primary focus is most likely due to the small size of this focus and its submucosal location, as well as with early metastasis to the lymph nodes.

Conclusion. In order not to miss clinically latent squamous cell carcinoma of the oropharynx, interdisciplinary collaboration and conduct of thorough immunohistological study, especially a surrogate marker test for Hpv p16, are needed.

About the authors

K. A. Zolotarev

N.N. Blokhin National Medical Research Center of Oncology, Ministry of Health of Russia; N.V. Sklifosovsky Institute of Clinical Medicine, Sechenov University, Ministry of Health of Russia; Oncological Center No. 1 – a branch of the S. S. Yudin City Clinical Hospital, Moscow Healthcare Department

Author for correspondence.
Email: zolotarev31@mail.ru
ORCID iD: 0000-0002-9015-7030

Konstantin Aleksandrovich Zolotarev

24 Kashirskoe Shosse, Moscow 115522

Bld.2, 11 Rossolimo St., Moscow 119021

18A Zagorodnoye Shosse, Moscow 117152

Russian Federation

A. M. Mudunov

N.V. Sklifosovsky Institute of Clinical Medicine, Sechenov University, Ministry of Health of Russia; Clinical Hospital “Lapino” of the “Mother and Child” Group of companies

Email: fake@neicon.ru
ORCID iD: 0000-0002-0918-3857

Bld.2, 11 Rossolimo St., Moscow 119021

111 1st Uspenskoe Shosse, Lapino,  Moscow Region 143081

Russian Federation

Yu. V. Alymov

N.N. Blokhin National Medical Research Center of Oncology, Ministry of Health of Russia

Email: fake@neicon.ru
ORCID iD: 0000-0002-6851-9867

24 Kashirskoe Shosse, Moscow 115522

Russian Federation

O. A. Saprina

N.N. Blokhin National Medical Research Center of Oncology, Ministry of Health of Russia

Email: fake@neicon.ru
ORCID iD: 0000-0002-2283-1812

24 Kashirskoe Shosse, Moscow 115522

Russian Federation

D. A. Peshko

N.N. Blokhin National Medical Research Center of Oncology, Ministry of Health of Russia; N.V. Sklifosovsky Institute of Clinical Medicine, Sechenov University, Ministry of Health of Russia; Federal Scientific and Clinical Center for Specialized Types of Medical Care and Medical Technologies of the Federal Medical and Biological Agency of Russia

Email: fake@neicon.ru
ORCID iD: 0000-0003-1611-4603

24 Kashirskoe Shosse, Moscow 115522

Bld.2, 11 Rossolimo St., Moscow 119021

28 Orekhovy Boul’var, Moscow 115682

Russian Federation

References

Supplementary files

Supplementary Files
Action
1. JATS XML

Copyright (c)



СМИ зарегистрировано Федеральной службой по надзору в сфере связи, информационных технологий и массовых коммуникаций (Роскомнадзор).
Регистрационный номер и дата принятия решения о регистрации СМИ: серия ПИ № ФС 77 - 36990 от  21.07.2009.